Gonococcal resistance: are cephalosporins next?
Robert D Kirkcaldy1, Ronald C Ballard, Deborah Dowell
1Division of STD Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, E-02, Atlanta, GA, 30333, USA, hgl8@cdc.gov.
Current Infectious Disease Reports
|March 3, 2011
Summary
Gonorrhea treatment is becoming limited due to antibiotic resistance. This review examines global cephalosporin resistance trends in Neisseria gonorrhoeae and its public health implications.
Area of Science:
- Microbiology
- Infectious Diseases
- Public Health
Background:
- Antibiotic resistance in Neisseria gonorrhoeae is a growing global concern.
- Limited treatment options exist for gonorrhea due to multidrug-resistant strains.
- Current guidelines recommend cephalosporins, but resistance is emerging.
Purpose of the Study:
- To review global trends in cephalosporin susceptibility of Neisseria gonorrhoeae.
- To explore genetic mechanisms of emerging resistance.
- To discuss the public health and clinical implications of cephalosporin-resistant gonorrhea.
Main Methods:
- Systematic review of global gonococcal isolates.
- Analysis of genetic mechanisms driving resistance.
- Evaluation of clinical and public health data.
Main Results:
- Increasing cephalosporin resistance observed in Neisseria gonorrhoeae globally.
- Identification of specific genetic factors contributing to resistance.
- Potential for widespread treatment failure if resistance escalates.
Conclusions:
- Cephalosporin resistance in gonorrhea poses a significant public health threat.
- Continued surveillance and research into resistance mechanisms are critical.
- Urgent strategies are needed to preserve the efficacy of current and future gonorrhea treatments.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...